Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/IRLAB-THERAPEUTICS-AB-61747292/actualite/IRLAB-Therapeutics-AB-publ-soumet-une-demande-de-reunion-de-fin-de-phase-2-avec-la-FDA-pour-le-pr-45588379/?utm_source=whatsapp&utm_medium=social&utm_campaign=share